Literature DB >> 3882562

Activation of mouse peritoneal adherent cells with N-acyl muramyl dipeptide derivatives.

K Nishimura, H Okumura, I Saiki, H Okuyama, I Azuma.   

Abstract

The effect of N-acyl derivatives of muramyl dipeptide (N-acetyl muramyl-L-alanyl-D-isoglutamine) on the activation of peritoneal adherent cells (PAC) in vivo and on the stimulation of nonspecific host resistance against Escherichia coli infection was examined in comparison with the effect of 6-O-stearoyl muramyl dipeptide. N-acyl muramyl dipeptide derivatives increased the release of hydrogen peroxide (H2O2) by PAC from mice treated 1 day before upon stimulation with phorbol myristate acetate, and their activities did not depend on the chain length or kinds of fatty acids introduced. The results obtained using N-stearoyl muramyl dipeptide analogs indicated that the acyl moiety combined to muramic acid played a more important role in the ability of PAC to release H2O2 than did the peptide moiety. PAC from mice treated with N-stearoyl muramyl dipeptide, N-(3-hydroxy-2-docosylhexacosanoyl) muramyl dipeptide, and 6-O-stearoyl muramyl dipeptide 1 day before, including 20 to 42% polymorphonuclear leukocytes, released large amount of H2O2, and most of the H2O2 released was due to the attribution of polymorphonuclear leukocytes. The cytostatic activity of PAC from mice treated with these three compounds reached a maximum on day 3 after injection, and the cytolytic activity of PAC was induced by N-stearoyl muramyl dipeptide on day 3 and by 6-O-stearoyl muramyl dipeptide on day 1 after injection. In contrast to the above results, N-acyl muramyl dipeptide derivatives did not stimulate nonspecific host resistance against E. coli infection in mice when compared to 6-O-stearoyl muramyl dipeptide.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882562      PMCID: PMC261350          DOI: 10.1128/iai.47.3.665-669.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.

Authors:  L Chedid; M Parant; F Parant; P Lefrancher; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

3.  Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants.

Authors:  D Juy; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

4.  Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide.

Authors:  N P Cummings; M J Pabst; R B Johnston
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

5.  Adjuvant activity of N-acetyl muramyl dipeptides for the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.

Authors:  I Azuma; K I Kamisango; I Saiki; Y Tanio; S Kobayashi; Y Yamamura
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

6.  Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.

Authors:  M A Parant; F M Audibert; L A Chedid; M R Level; P L Lefrancier; J P Choay; E Lederer
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

7.  Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity.

Authors:  C F Nathan; S C Silverstein; L H Brukner; Z A Cohn
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

8.  Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide.

Authors:  M J Pabst; R B Johnston
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

9.  Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide.

Authors:  C F Nathan; L H Brukner; S C Silverstein; Z A Cohn
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

10.  Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages.

Authors:  M Sasada; R B Johnston
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.